Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring
59:50
Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality Testing
1:01:18
2022 Jan26 Webinar
1:02:19
Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies
59:36
Invivoscribe - 2019 MRD Webinar - Memorial Sloan Kettering & Children's Hospital Los Angeles
59:12
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms and Primers
59:21
Clinical Utility of NGS in Lymphoid Malignancies
43:27
Lab Secrets: The Potential for NGS Based MRD Testing for Acute Lymphoblastic Leukemia
56:03